Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
DigitalOptometrics Launches Real-Time Translation Service
DigitalOptometrics has unveiled a revolutionary solution to enhance patient care with the launch of “DOT” (DigitalOptometrics Translate), a real-time translation service designed to break down language barriers in the optometric industry. The innovative “DOT” technology facilitates seamless communication between eye…
New Study Reveals Insights into Glaucoma in Africans
A team of investigators unveiled previously unknown inherited genetic variants associated with primary open-angle glaucoma (POAG), the most prevalent form of the disease. The study, based on the analysis of 11,275 individuals of African descent, sheds light on the genetic…
iuvo BioScience Completes Acquisition of Promedica
iuvo BioScience, a prominent Partner Research Organization (PROTM), announced its successful acquisition of Promedica International, a California Corporation, specializing in ophthalmology-focused clinical Contract Research Organization (CRO) services. The strategic move is poised to create a global leader in delivering comprehensive…
OBN Spotlight TV: Interview with Filomena Ribeiro, MD
Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…
Gentex Acquires eSight to Develop Electronic Eyewear
Gentex, a global leader in electro-optical products, announced a significant move towards enhancing accessibility with the acquisition of eSight, a leading company in vision enhancement technologies. The strategic acquisition is aimed at developing and manufacturing next-generation mobile electronic eyewear, specifically…
Aviceda Launches Phase 2 Clinical Trial for AVD-104
Aviceda Therapeutics announced a significant milestone in the development of its lead ophthalmic candidate, AVD-104, with the enrollment of the first patient in the GLYCO phase 2 US clinical trial. The trial aims to evaluate the efficacy and safety of…
Study Unveils Pupil Response Discrepancy in Depression Patients
In a recent study conducted by scientists from the Max Planck Institute of Psychiatry, researchers delved into the realm of pupillary reactions to uncover valuable insights into the physiological mechanisms underlying depression. The study, led by research group leader Victor…
FDA Approves ZEISS’ VISUMAX® 800 for Nearsightedness
The FDA has approved the VISUMAX® 800 equipped with SMILE® pro software from ZEISS. This state-of-the-art femtosecond laser technology is designed for the surgical treatment of nearsightedness, with or without astigmatism. The VISUMAX® 800 enters the U.S. market at a…
UCI Secures $575K Grant for Ophthalmology Research
The University of California, Irvine School of Medicine announced the reception of a prestigious Unrestricted Grant from the esteemed nonprofit organization, Research to Prevent Blindness (RPB). The substantial grant, amounting to $575,000 over a five-year period, will be dedicated to…
Leading the AI Ophthalmology Revolution – Johns Hopkins Medicine
Leading the AI Ophthalmology Revolution Johns Hopkins Medicine Source: Author: | Date: 2024-01-08 08:00:00 Source: Author: | Date: 2024-01-08 08:00:00